×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Section 218: Advanced Nutritional Genomics and Personalized
therapeutic
1,573 words
KG: ent-dise-bfd8f32d
section:therapeutics
kind:therapeutic
topic:cbs
topic:psp
topic:nutrigenomics
topic:personalized-medicine
topic:nutrition
topic:vitamins
Contents
Section 218: Advanced Nutritional Genomics and Personalized Diet in CBS/PSP
💊
Therapeutic Info
Name
Section 218: Advanced Nutritional Genomics and Personalized Diet in CBS/PSP
Summary
Nutrigenomics for CBS/PSP: MTHFR, VDR, APOE, SOD2 variants affecting vitamin D, B vitamins, CoQ10, methylation, personalized diet based on genetic profile
Knowledge Graph
Related Hypotheses (20)
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Purinergic Signaling Polarization Control
Score: 0.55
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
APOE Isoform Conversion Therapy
Score: 0.44
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44
Extracellular Matrix Stiffness Modulation
Score: 0.43
Show 15 more
Related Analyses (8)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Show 3 more
Related Experiments (15)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Show 10 more
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 5 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 5 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 5 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 5 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 5 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 5 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 5 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 5 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 5 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 5 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 5 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 5 hypotheses
SUMOylation in Neurodegeneration
mechanism · Pages share 5 hypotheses
Show 10 more